{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:49:39Z","timestamp":1792205379334,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.intimp.2024.112485","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T21:14:19Z","timestamp":1718399659000},"page":"112485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2\/CD36 pathway"],"prefix":"10.1016","volume":"137","author":[{"given":"Kai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9570-2891","authenticated-orcid":false,"given":"Qingyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J (engl)."},{"issue":"19","key":"10.1016\/j.intimp.2024.112485_b0010","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA."},{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin."},{"issue":"10064","key":"10.1016\/j.intimp.2024.112485_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet."},{"issue":"7441","key":"10.1016\/j.intimp.2024.112485_b0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.intimp.2024.112485_b0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7150\/thno.29678","article-title":"Circular RNAs in immune responses and immune diseases","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-019-1125-9","article-title":"Roles of circRNAs in the tumour microenvironment","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer."},{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41419-020-2441-0","article-title":"CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the Hedgehog pathway through the regulation of miR-15a-5p\/15b-5p and GLI2 expressions","volume":"11","author":"He","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jcp.29481","article-title":"FUS-induced circular RNA ZNF609 promotes tumorigenesis and progression via sponging miR-142-3p in lung cancer","volume":"236","author":"Liu","year":"2021","journal-title":"J Cell Physiol."},{"key":"10.1016\/j.intimp.2024.112485_b0050","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.2147\/CMAR.S174778","article-title":"CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res."},{"key":"10.1016\/j.intimp.2024.112485_b0055","article-title":"CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200\/CDC25B pathway","author":"Feng","year":"2022","journal-title":"Cell Biol Toxicol"},{"issue":"12","key":"10.1016\/j.intimp.2024.112485_b0060","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest."},{"key":"10.1016\/j.intimp.2024.112485_b0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ctrv.2018.03.007","article-title":"The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review","volume":"66","author":"Khetrapal","year":"2018","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer."},{"issue":"15","key":"10.1016\/j.intimp.2024.112485_b0075","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell","year":"2013","journal-title":"Cell Mol Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-022-01608-7","article-title":"CircEZH2\/miR-133b\/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA","volume":"21","author":"Yao","year":"2022","journal-title":"Mol Cancer."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.112485_b0085","article-title":"m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R\/JAK1\/STAT3 signaling by sponging miR-647","volume":"124","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13578-023-01148-7","article-title":"SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc","volume":"13","author":"Qiao","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","article-title":"m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma","volume":"22","author":"Fang","year":"2023","journal-title":"Mol Cancer."},{"issue":"10","key":"10.1016\/j.intimp.2024.112485_b0100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41419-023-06163-7","article-title":"IGF2BP2-meidated m(6)A modification of CSF2 reprograms MSC to promote gastric cancer progression","volume":"14","author":"Ji","year":"2023","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.intimp.2024.112485_b0105","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/S0022-2275(20)33310-1","article-title":"Membrane transport of long-chain fatty acids: evidence for a facilitated process","volume":"39","author":"Abumrad","year":"1998","journal-title":"J Lipid Res."},{"issue":"7635","key":"10.1016\/j.intimp.2024.112485_b0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature."},{"issue":"478","key":"10.1016\/j.intimp.2024.112485_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5758","article-title":"Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer","volume":"11","author":"Watt","year":"2019","journal-title":"Sci Transl Med."},{"issue":"15","key":"10.1016\/j.intimp.2024.112485_b0120","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.cub.2021.05.013","article-title":"Mitotic recombination between homologous chromosomes drives genomic diversity in diatoms","volume":"31","author":"Bulankova","year":"2021","journal-title":"Curr Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0125","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-023-02614-3","article-title":"HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1\/PKM2 pathway","volume":"42","author":"Lv","year":"2023","journal-title":"J Exp Clin Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2024.112485_b0135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.tem.2020.05.007","article-title":"The Diverse Functions of IMP2\/IGF2BP2 in Metabolism","volume":"31","author":"Dai","year":"2020","journal-title":"Trends Endocrinol Metab."},{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-Induced circARHGAP29 Promotes Aerobic Glycolysis in Docetaxel-Resistant Prostate Cancer through IGF2BP2\/c-Myc\/LDHA Signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112485_b0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112485_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121605","article-title":"The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target","volume":"12","author":"Feng","year":"2023","journal-title":"Cells."},{"issue":"7","key":"10.1016\/j.intimp.2024.112485_b0155","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell."},{"issue":"9\u201310","key":"10.1016\/j.intimp.2024.112485_b0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1101\/gad.314856.118","article-title":"A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs","volume":"32","author":"Huang","year":"2018","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cac2.12284","article-title":"HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program","volume":"42","author":"Huang","year":"2022","journal-title":"Cancer Commun (lond)."},{"issue":"11","key":"10.1016\/j.intimp.2024.112485_b0170","doi-asserted-by":"crossref","first-page":"e2205613","DOI":"10.1002\/advs.202205613","article-title":"ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci (weinh)."},{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.112485_b0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The Roles of CD8(+) T Cell Subsets in Antitumor Immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112485_b0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.20120162","article-title":"Targeting glucose metabolism for cancer therapy","volume":"209","author":"Hamanaka","year":"2012","journal-title":"J Exp Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer."},{"issue":"2","key":"10.1016\/j.intimp.2024.112485_b0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","article-title":"Lactate: A Metabolic Driver in the Tumour Landscape","volume":"44","author":"Ippolito","year":"2019","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.intimp.2024.112485_b0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","article-title":"Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation","volume":"43","author":"Huber","year":"2017","journal-title":"Semin Cancer Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112485_b0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8(+) T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell."},{"issue":"6","key":"10.1016\/j.intimp.2024.112485_b0210","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","article-title":"Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development","volume":"6","author":"Baenke","year":"2013","journal-title":"Dis Model Mech."},{"issue":"8","key":"10.1016\/j.intimp.2024.112485_b0215","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tcb.2014.06.001","article-title":"Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment","volume":"24","author":"Ackerman","year":"2014","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0220","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis."},{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0225","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1021\/acsnano.2c11159","article-title":"Regulating the Obesity-Related Tumor Microenvironment to Improve Cancer Immunotherapy","volume":"17","author":"Fang","year":"2023","journal-title":"ACS Nano."},{"key":"10.1016\/j.intimp.2024.112485_b0230","doi-asserted-by":"crossref","first-page":"1020422","DOI":"10.3389\/fimmu.2022.1020422","article-title":"Lipids for CD8(+) TILs: Beneficial or harmful?","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112485_b0235","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity."},{"issue":"2","key":"10.1016\/j.intimp.2024.112485_b0240","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/0008-5472.CAN-14-2277","article-title":"Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics","volume":"75","author":"Crompton","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41590-020-00818-9","article-title":"MEK inhibition reprograms CD8(+) T lymphocytes into memory stem cells with potent antitumor effects","volume":"22","author":"Verma","year":"2021","journal-title":"Nat Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0250","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41467-023-38232-y","article-title":"Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy","volume":"14","author":"Dong","year":"2023","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-019-1111-2","article-title":"Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-020-01648-1","article-title":"Circular RNA circ-CPA4\/ let-7 miRNA\/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)","volume":"39","author":"Hong","year":"2020","journal-title":"J Exp Clin Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","article-title":"N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer","volume":"20","author":"Liu","year":"2021","journal-title":"Mol Cancer."},{"issue":"12","key":"10.1016\/j.intimp.2024.112485_b0270","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell."},{"issue":"8","key":"10.1016\/j.intimp.2024.112485_b0275","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1515\/hsz-2013-0111","article-title":"Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains","volume":"394","author":"Wachter","year":"2013","journal-title":"Biol Chem."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0280","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-021-01799-x","article-title":"The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.intimp.2024.112485_b0285","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/sji.12307","article-title":"Overexpression of IGF2 mRNA-Binding Protein 2 (IMP2\/p62) as a Feature of Basal-like Breast Cancer Correlates with Short Survival","volume":"82","author":"Barghash","year":"2015","journal-title":"Scand J Immunol."},{"key":"10.1016\/j.intimp.2024.112485_b0290","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2147\/OTT.S232795","article-title":"Tumor Suppressor microRNA-138 Suppresses Low-Grade Glioma Development and Metastasis via Regulating IGF2BP2","volume":"13","author":"Yang","year":"2020","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.intimp.2024.112485_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.578816","article-title":"IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism","volume":"10","author":"Pu","year":"2020","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112485_b0300","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J Exp Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.112485_b0305","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.intimp.2024.112485_b0310","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity."},{"issue":"3","key":"10.1016\/j.intimp.2024.112485_b0315","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","article-title":"CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors","volume":"21","author":"Wang","year":"2020","journal-title":"Nat Immunol."},{"key":"10.1016\/j.intimp.2024.112485_b0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003330","article-title":"CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients","author":"Rech","year":"2012413413462","journal-title":"Sci Transl Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.112485_b0325","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.194.6.823","article-title":"Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses","volume":"194","author":"Sutmuller","year":"2001","journal-title":"J Exp Med."},{"key":"10.1016\/j.intimp.2024.112485_b0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-319-60733-7_6","article-title":"RNA Nuclear Export: From Neurological Disorders to Cancer","volume":"1007","author":"Hautbergue","year":"2017","journal-title":"Adv Exp Med Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112485_b0335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-020-00903-4","article-title":"XPO1-dependent nuclear export as a target for cancer therapy","volume":"13","author":"Azizian","year":"2020","journal-title":"J Hematol Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112485_b0340","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1002\/ctm2.360","article-title":"Novel circular RNA circSOBP governs amoeboid migration through the regulation of the miR-141-3p\/MYPT1\/p-MLC2 axis in prostate cancer","volume":"11","author":"Chao","year":"2021","journal-title":"Clin Transl Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:37:17Z","timestamp":1720280237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924010063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":68,"alternative-id":["S1567576924010063"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112485","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2\/CD36 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112485"}}